NXTC
Income statement / Annual
Last year (2023), NextCure, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, NextCure, Inc.'s net income was -$62.72 M.
See NextCure, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$22.38 M
|
$6.35 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3.68 M |
$4.48 M |
$4.30 M |
$46,554.00 |
$34,216.00 |
$1.68 M |
$582,000.00 |
| Gross Profit |
-$3.68 M |
-$4.48 M |
-$4.30 M |
$22.33 M |
$6.31 M |
-$1.68 M |
-$582,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
1 |
0.99 |
0 |
0 |
| Research and Development
Expenses |
$47.93 M
|
$54.20 M
|
$50.19 M
|
$46.55 M
|
$34.22 M
|
$19.79 M
|
$12.95 M
|
| General & Administrative
Expenses |
$19.71 M
|
$21.71 M
|
$20.57 M
|
$17.05 M
|
$9.61 M
|
$3.41 M
|
$2.60 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$19.71 M
|
$21.71 M
|
$20.57 M
|
$17.05 M
|
$9.61 M
|
$3.41 M
|
$2.60 M
|
| Other Expenses |
$0.00 |
$1.18 M |
$1.38 M |
$4.62 M |
$3.75 M |
$397,000.00 |
$80,000.00 |
| Operating Expenses |
$67.64 M |
$75.91 M |
$70.77 M |
$63.60 M |
$43.83 M |
$23.20 M |
$15.55 M |
| Cost And Expenses |
$67.64 M |
$75.91 M |
$70.77 M |
$63.60 M |
$43.83 M |
$23.20 M |
$15.55 M |
| Interest Income |
$0.00 |
$1.17 M |
$1,319.00 |
$4,552.00 |
$3,745.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$77,000.00 |
$183,000.00 |
$209,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3.68 M
|
$4.48 M
|
$4.30 M
|
$3.41 M
|
$2.69 M
|
$1.68 M
|
$582,000.00
|
| EBITDA |
-$59.04 M
|
-$70.25 M
|
-$65.01 M
|
-$37.81 M
|
-$34.79 M
|
-$21.10 M
|
-$14.97 M
|
| EBITDA Ratio |
0 |
0 |
0 |
-1.84 |
-5.48 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
-1.84
|
-5.91
|
0
|
0
|
| Total Other
Income/Expenses Net |
$4.91 M
|
$1.18 M
|
$1.38 M
|
$4.62 M
|
$3.75 M
|
$397,000.00
|
$80,000.00
|
| Income Before Tax |
-$62.72 M |
-$74.73 M |
-$69.39 M |
-$36.60 M |
-$33.74 M |
-$22.80 M |
-$15.47 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
-1.64
|
-5.32
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$5.30 M |
$6.96 M |
-$3.41 M |
$2.52 M |
$397,000.00 |
$0.00 |
| Net Income |
-$62.72 M |
-$69.43 M |
-$69.39 M |
-$33.19 M |
-$33.74 M |
-$22.80 M |
-$15.47 M |
| Net Income Ratio |
0 |
0 |
0 |
-1.48 |
-5.32 |
0 |
0 |
| EPS |
-2.25 |
-2.5 |
-2.51 |
-1.21 |
-2.15 |
-2.27 |
-1.54 |
| EPS Diluted |
-2.25 |
-2.5 |
-2.51 |
-1.21 |
-2.15 |
-2.27 |
-1.54 |
| Weighted Average Shares
Out |
$27.84 M
|
$27.74 M
|
$27.62 M
|
$27.53 M
|
$15.70 M
|
$10.04 M
|
$10.04 M
|
| Weighted Average Shares
Out Diluted |
$27.84 M
|
$27.74 M
|
$27.62 M
|
$27.53 M
|
$15.70 M
|
$10.04 M
|
$10.04 M
|
| Link |
|
|
|
|
|
|
|
